A federal jury has ordered drugmaker Pfizer to pay at least $142 million in damages for misleading the Kaiser Health Plan Inc. about the uses of its epilepsy drug Neurontin. According to the judgment, Pfizer misled the health provider into believing Neurontin was effective at treating bipolar disorder and migraines, uses for which Kaiser doctors still prescribe the drug. The jury's ruling was based on Pfizer's violation of federal anti-racketeering laws.
Read moreLast week, the United States Food and Drug Administration (FDA) made it official: Lyrica, the trade name of the Pfizer drug pregabalin, was... Read more »
New research, funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (one of the National Institutes of... Read more »
The health care professions are all facing an aging and rising tide of baby boomers, and many of these patients are going to be suffering... Read more »
The New York Times stirred up some old controversies recently with their article on fibromyalgia called "Drug Approved. Is Disease Real?" ... Read more »
FullQuestion:I have been suffering from chronic cluster headaches for the past 20 years since I was 25. After numerous CT's and MRI tests... Read more »
Source: First DataBank
Generic Name: GABAPENTIN SOLUTION - ORAL Pronounced: (gab-uh-PEN-tin) Overdose If overdose is suspected, contact your local poison control center... Read more »
Drugmaker Pfizer says that the drug Sutent did not meet expectations in two late-stage trials for advanced breast cancer. The studies paired the... Read more »
Neuronal stabilizing agents, aka anticonvulsants or antiepileptic drugs, are among the most prescribed medications for Migraine and headache... Read more »